Multiple Sclerosis Trial, Recruiting NCT05772637 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT05772637
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who have been diagnosed with Multiple Sclerosis (MS) according to a standard set of medical guidelines called the 2017 McDonald criteria
  • People who have bladder problems that are thought to be connected to their MS
  • People who have been recommended to have a bladder function test called urodynamics
  • People who are not currently taking any medication for bladder problems
  • People who can read and write in French
  • People who are covered by French public health insurance (Sécurité Sociale, Couverture Médicale Universelle, or an equivalent scheme)

Who may not be able to join:

  • People who are under a legal protection order (such as court-appointed guardianship)
  • People who are pregnant or currently breastfeeding
  • People who have had an MS relapse (a flare-up of symptoms) within the past month
  • People who have another neurological condition in addition to MS
  • People who have stress-related bladder leakage that is directly linked to childbirth
  • People who have taken certain bladder medications (antimuscarinics, alpha blockers, or beta-3 adrenergic drugs) or had tibial nerve stimulation within the past 15 days, or who have had botulinum toxin (Botox) injections for bladder issues within the past 6 months
  • People who have had surgery on the lower urinary tract (bladder or urethra) in the past
  • People who are unable to use a handheld analogue device due to difficulties with movement, sensation, or coordination

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0156017500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
14 February 2024
Est. completion
14 February 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

bladder sensation ( area under the sensation-capacity curve (AUC))

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov